Lisa Gopalakrishnan
Plus aucun poste en cours
Profil
Lisa Gopala has been Executive Vice President and Chief Financial Officer of Abraxis Bioscience, Inc. since August 10, 2006.
She joined Abraxis BioScience in July 2006.
Prior to joining Abraxis, Ms. Gopala served as Executive Vice President and Chief Financial Officer of Intermix Media, Inc. Prior to Intermix Media, she was Vice President-Finance and Controller of Ticketmaster.
Ms. Gopala served at International Rectifier, LA Gear and PricewaterhouseCoopers/Arthur Andersen.
She was Chief Financial Officer and Executive Vice President of APP Pharmaceuticals, Inc. She is a Certified Public Accountant and received a BS in Business Administration from Babson College in Wellesley, Massachusetts.
Anciens postes connus de Lisa Gopalakrishnan
| Sociétés | Poste | Fin |
|---|---|---|
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Directeur Financier/CFO | 21/05/2008 |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Directeur Financier/CFO | 29/04/2008 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Directeur Financier/CFO | 15/11/2007 |
Intermix Media, Inc.
 Intermix Media, Inc. Miscellaneous Commercial ServicesCommercial Services Intermix Media, Inc. provides online media, eCommerce, Internet marketing and entertainment services. It offers services to the corporate and private sectors. The company was founded by Joseph Abrams, Brad D. Greenspan, Joe Marrapodi and Brett C. Brewer in 1999 and is headquartered in Beverly Hills, CA. | Directeur Financier/CFO | 01/10/2005 |
Ticketmaster Entertainment, Inc.
 Ticketmaster Entertainment, Inc. Catalog/Specialty DistributionRetail Trade Ticketmaster Entertainment, Inc. sells sporting, concert and other tickets through its call centers, network of sales outlets and the Internet, charging a handling fee to its customers. It provides ticket sales, ticket resale services, marketing and distribution of event tickets and information. The company was founded in 1976 and is headquartered in West Hollywood, CA. | Directeur Financier/CFO | 01/04/2005 |
Formation de Lisa Gopalakrishnan
| Babson College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Intermix Media, Inc.
Intermix Media, Inc. Miscellaneous Commercial ServicesCommercial Services Intermix Media, Inc. provides online media, eCommerce, Internet marketing and entertainment services. It offers services to the corporate and private sectors. The company was founded by Joseph Abrams, Brad D. Greenspan, Joe Marrapodi and Brett C. Brewer in 1999 and is headquartered in Beverly Hills, CA. | Commercial Services |
Ticketmaster Entertainment, Inc.
Ticketmaster Entertainment, Inc. Catalog/Specialty DistributionRetail Trade Ticketmaster Entertainment, Inc. sells sporting, concert and other tickets through its call centers, network of sales outlets and the Internet, charging a handling fee to its customers. It provides ticket sales, ticket resale services, marketing and distribution of event tickets and information. The company was founded in 1976 and is headquartered in West Hollywood, CA. | Retail Trade |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |